The report covers aspects such as pharmaceutical market segment (by Prescription & OTC Drugs, by Patented & Generic Drugs), competitive landscape of major players in the Singapore pharmaceutical market... For more information on the research report, refer to below link: https://www.kenresearch.com/healthcare/pharmaceuticals/singapore-pharmaceutical-market/149668-91.html
This report is an essential reference for who looks for detailed information on North America Over the Counter (OTC) Drugs & Dietary Supplements market. The report covers data on North America markets including historical and future trends for supply, market size, prices, trading,
A newly published report by Market Statsville Group (MSG), title Global OTC Drugs Market provides an exhaustive analysis of significant industry insights and historical and projected global market figures. MSG expects the global OTC Drugs market will showcase an impressive CAGR from 2024 to 2033. The comprehensive OTC
The global OTC drugs market is estimated to garner a revenue of ~ USD 294 billion by the end of 2035 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2035.
According to the latest research report by IMARC Group, The global over the counter (OTC) drugs market size reached US$ 168.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 275.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032. More Info:- https://www.imarcgroup.com/over-the-counter-drugs-market
For more information kindly visit : https://www.bharatbook.com/drugs-market-research-reports-400900/otc-drugs-china1.html Bharat Book Bureau provides the report, on “ OTC Drugs Markets in China”. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants.
The global over the counter drugs & dietary supplements market is driven by growth in awareness related to general health concerns and advancements in healthcare and pharmaceutical industries. In addition, growing trend among individuals to select OTC drugs for minor diseases supplements the market growth.
According to the latest research report by IMARC Group, The global over the counter (OTC) drugs market size reached US$ 158.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 231.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.24% during 2023-2028. More info:- https://www.imarcgroup.com/over-the-counter-drugs-market
According to the latest research report by IMARC Group, The United States over the counter (OTC) drugs market size reached US$ 25.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.45% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-over-the-counter-drugs-market
According to the latest research report by IMARC Group, The India over the counter (OTC) drugs market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.4 Billion by 2028, exhibiting a growth rate (CAGR) of 16.7% during 2023-2028. More Info:- https://www.imarcgroup.com/india-over-the-counter-drugs-market
According to the latest research report by IMARC Group, The global over the counter (OTC) drugs market size reached US$ 158.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 231.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.24% during 2023-2028. More Info:- https://www.imarcgroup.com/over-the-counter-drugs-market
OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country. Analysts forecast the global gastrointestinal OTC drugs market to grow at a CAGR of 1.48% over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-gastrointestinal-otc-drugs-2015-2019-market
This report studies the Global Gastrointestinal OTC Drugs market status and forecast, categorizes the global Gastrointestinal OTC Drugs market size (value & volume) by manufacturers, type, application, and region.
Big Market Research “OTC Drugs Markets in China” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/otc-drugs-in-china-market China’s demand for OTC Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
Global Over the Counter OTC Drugs & Dietary Supplements market competition by top manufacturers, with production, price, revenue value and market share for each manufacturer; the top players including Pfizer Novartis International Roche Holding Merck Sanofi Johnson & Johnson
The Global Over-the-counter (OTC) drugs market share report provides numbers for applications and regional segments of the industry covering historical as well as forecast data for decision makers.
Big Market Research present “OTC Pharmaceuticals Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2018. Visit for more info @ http://www.bigmarketresearch.com/otc-pharmaceuticals-in-latin-america-2014-2018-market The OTC Pharmaceuticals Market in Latin America market to grow at a CAGR of 14.54 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs.
Indonesia Pharmaceutical market has registered an increase in the revenue at a CAGR of ~% from USD ~ billion in 2012 to USD ~ billion in 2017. For more information on the research report, refer to below link: https://www.kenresearch.com/healthcare/pharmaceuticals/indonesia-pharmaceutical-market/143542-91.html
Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of disease. These OTC need to be labelled safe, effective, pure and accurate by the concerned government authority before they could go into the market.
Over-The-Counter (OTC) Drugs Market size is expected to grow rapidly during the forecast period due to rising geriatric population and increasing demand from patients to treat various medical conditions without requiring physician’s consultation. As per WHO estimates, the worldwide elderly population aged 65 years and above is set to rise to 16% by 2050 from 7% in 2000, fueling the demand for medicines in the future.
The Over-the-Counter (OTC) drug market, valued at an impressive $162.2 billion in 2022, steps in. Projected to reach a staggering $245.9 billion by 2032, with a healthy CAGR of 5.3%.
By exploring and comparing these key 4 markets aim to give the reader the best indication of how these markets will progress to 2025; which OTC areas will offer the most growth and what location specific issues any entrant to the respective OTC markets can face.
Global otc drug and dietary supplement market size is expected to reach $438.93 Bn by 2028 at a rate of 7.2%, segmented as by category, vitamin and dietary supplements, cough and cold products, analgesics, gastrointestinal products, sleep aids
The dermatology OTC medications market is expected to grow from US$ 15,456.63 million in 2021 to US$ 21,313.40 million by 2028; it is estimated to grow at a CAGR of 4.7% from 2021 to 2028. https://www.theinsightpartners.com/reports/dermatology-otc-medications-market
The Over-the-counter drug market is flourishing. According to a report by Ken Research, the global OTC Drug market size reached a substantial $137.39 billion in 2024 and is projected to reach a staggering $163.10 billion by 2029, boasting a healthy CAGR (Compound Annual Growth Rate) of 3.49%.
The global pharmaceutical drugs market was valued around $935 billion in 2017. North America was the largest region in the pharmaceutical drugs market in 2017, accounting for around 37% of the total market. The USA was the largest country in the market accounting for around 25% of the total market.
Over The Counter Drugs (OTC) Dina R. Utter MSN Student Viterbo University Prescription vs. Non Prescription (OTC) Drugs Determined by the U.S. Food and Drug ...
Inkwood Research estimates that the Global OTC Artificial Tears Market is set to grow with a CAGR of 5.12% in terms of revenue during the forecasting years of 2021-2028.
According to the latest research report by IMARC Group, The India over the counter (OTC) drugs market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.4 Billion by 2028, exhibiting a growth rate (CAGR) of 16.7% during 2023-2028. More Info:- https://www.imarcgroup.com/india-over-the-counter-drugs-market
Big Market Research present “Global Anti-Obesity Drugs Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-anti-obesity-drugs-2015-2019-market Obesity is a medical condition in which there is surplus accumulation of fat in the body. It is linked with increased illness risk, disability, and death. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure.
The collection of ‘Over the Counter (OTC) Drug’ market research reports has a new addition of “OTC market in Central Europe 2013.Comparative analysis and development forecasts for 2013-2015” on RnRMarketResearch.com. OTC market in Central Europe 2013. Comparative analysis and development forecasts for 2013-2015. Track development in Central Europe’s OTC markets to 2015. Benefit from detailed forecasts, comparative analysis and data on markets in six countries. As regulations evolve in markets around the world with respect to over the counter drugs and dietary supplements gain in consumer popularity, it makes sense to keep tabs on market development and expansion for the next few years. Professionals involved in the manufacture, distribution and retail sale of over the counter preparations are searching for the latest information on this market.
North America was the largest region in the dermatology drugs market in 2017, accounting for around 31% market share. The USA was the largest country in the market in 2017, accounting for over 24% market share. Read Report https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report-2018
The global antiobesity market is expected to grow from $1.46 billion in 2020 to $2.4 billion in 2021 at a compound annual growth rate (CAGR) of 64.4%. The market is expected to reach $5.42 billion in 2025 at a CAGR of 22.6%.
Ophthalmology Drugs Market presents insights on the current and future industry trends, which helps to drive the revenue growth and profitability - says TBRC. https://bit.ly/2OoT2V1
Data Bridge Market Research analyses that the infertility testing market to account USD 722.59 by 2028 and growing at a CAGR of 6.75% in the forecast period of 2021-2028. https://www.databridgemarketresearch.com/reports/global-infertility-testing-market
Antiglaucoma Drugs Industry Research is the latest report by The Business Research Company, which throws light on specific drivers, restraints, opportunities, challenges and other factors that oppose market growth. https://bit.ly/3aRwkjU
Drugs for Lipid Metabolism Disease, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
Get a sample brochure @ http://tinyurl.com/z74unvm Analgesics, also known as painkillers, are used to treat and reduce pain in the body. Typically, they are used when the pain is severe and becomes unbearable for the patient. Non-opioids, opioids, and compound analgesics (a combination of both opioids and non-opioids) are the major analgesic products used globally. The emergence of analgesics is mainly attributed to the increase in acute and chronic diseases, as well as the rising incidence of cancer worldwide. Opioid drugs are the strongest types of analgesics, which are derived from opium.
Looking forward, the acne drugs market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/acne-drugs-market
The global ophthalmic drugs market is estimated to grow at an approximate CAGR of 7.86% during the period of 2017 and 2024.An existing predominance and increase in the number of eye disorders with growing geriatric population all over the world are the primary drivers responsible for the market growth.
The major players covered in the Dry Eye Medication Market are Allergan Plc., Alcon Inc., Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co, Ltd.. @ @ https://bit.ly/3hQB2Ti
The webinar will offer an overview of FDA requirements for marketing, labelling and promotion of OTC drugs in the U.S. It will cover how OTC pharmacy can be effectively marketed and the OTC Monographs and their importance to compliance in general and drug labels in particular. Challenges of marketing OTC drugs in the U.S. will be covered.
Get market research reports about Kuwait Pharmaceuticals Market Research Report, Respiratory Pharmaceutical Market Kuwait, Anti Inflammatory Drugs Market Kuwait, Musculoskeletal Drugs Market Kuwait online at kenresearch.com To know more, click on the link below: https://www.kenresearch.com/healthcare/pharmaceuticals/kuwait-pharmaceuticals-market/173389-91.html
Turkey Pharmaceuticals and Healthcare Report Q3 2014 @ http://www.lifescienceindustryresearch.com/turkey-pharmaceuticals-and-healthcare-report-q3-2014.html BMI View: Data released by the Turkish drugmakers association for 2013 sales corresponds with our own forecasts. We have also modified our pharmaceutical sales forecast for 2014 and beyond to reflect the volatile exchange rate situation. We now see Turkey’s lustre as an emerging pharmaceutical market regressing over the medium term. We believe that the business environment will continue to impede the industry and see very little scope for the central government to enact business-friendly reform in the sector. In sum, we believe 2014 will be another disappointing and challenging year for the industry.
The organized pharmacy retail market in India is primarily occupied by three main market players which are Apollo Pharmacy, MedPlus and Guardian Life care. Apollo is the leading the market players with ~ stores across India in FY’2015 and it has commanded ~% of market share in organized retail industry. Med Plus’s average annual sale per outlet is INR ~ million per store and it has a ~% market share in organized market.
Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.